APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Skin Patch

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Transdermal Skin Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchTransdermal Skin Patch Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Skin Patch Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Transdermal Skin Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Skin Patch Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Skin Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Transdermal Skin Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Skin Patch include Actavis, Changzhou Siyao, Henan Lingrui Pharmaceutical, Hisamitsu Pharmaceutical, Luye Pharma Group Ltd., Mundipharma, Purdue Pharma L.P., Rfl Pharmaceutical and Teikoku Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transdermal Skin Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Skin Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Skin Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Skin Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Skin Patch Segment by Company

Actavis

Changzhou Siyao

Henan Lingrui Pharmaceutical

Hisamitsu Pharmaceutical

Luye Pharma Group Ltd.

Mundipharma

Purdue Pharma L.P.

Rfl Pharmaceutical

Teikoku Pharma

Mylan

Novartis

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

Transdermal Skin Patch Segment by Type

Buprenorphine Transdermal Skin Patch

Fentanyl Transdermal Skin Patch

Clonidine Transdermal Skin Patch

Nicotine Transdermal Skin Patch

Transdermal Skin Patch Segment by Application

Relieve Severe Pain

Stop Smoking Cigarettes

Treat an Overactive Bladder

Others

Transdermal Skin Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Skin Patch market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Transdermal Skin Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Transdermal Skin Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Transdermal Skin Patch Industry Trends Table 2. Transdermal Skin Patch Industry Drivers Table 3. Transdermal Skin Patch Industry Opportunities and Challenges Table 4. Transdermal Skin Patch Industry Restraints Table 5. Global Transdermal Skin Patch Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Transdermal Skin Patch Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Transdermal Skin Patch Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Transdermal Skin Patch Sales Market Share by Manufacturers Table 9. Global Transdermal Skin Patch Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Transdermal Skin Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Transdermal Skin Patch Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Transdermal Skin Patch Manufacturers, Product Type & Application Table 13. Global Transdermal Skin Patch Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Skin Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Buprenorphine Transdermal Skin Patch Table 17. Major Manufacturers of Fentanyl Transdermal Skin Patch Table 18. Major Manufacturers of Clonidine Transdermal Skin Patch Table 19. Major Manufacturers of Nicotine Transdermal Skin Patch Table 20. Global Transdermal Skin Patch Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 22. Global Transdermal Skin Patch Sales by Type (2027-2032) & (W Units) Table 23. Global Transdermal Skin Patch Sales Market Share by Type (2021-2026) Table 24. Global Transdermal Skin Patch Sales Market Share by Type (2027-2032) Table 25. Global Transdermal Skin Patch Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Transdermal Skin Patch Revenue by Type (2021-2026) & (W Units) Table 27. Global Transdermal Skin Patch Revenue by Type (2027-2032) & (W Units) Table 28. Global Transdermal Skin Patch Revenue Market Share by Type (2021-2026) Table 29. Global Transdermal Skin Patch Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Relieve Severe Pain Table 31. Major Manufacturers of Stop Smoking Cigarettes Table 32. Major Manufacturers of Treat an Overactive Bladder Table 33. Major Manufacturers of Others Table 34. Global Transdermal Skin Patch Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 36. Global Transdermal Skin Patch Sales by Application (2027-2032) & (W Units) Table 37. Global Transdermal Skin Patch Sales Market Share by Application (2021-2026) Table 38. Global Transdermal Skin Patch Sales Market Share by Application (2027-2032) Table 39. Global Transdermal Skin Patch Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 40. Global Transdermal Skin Patch Revenue by Application (2021-2026) & (W Units) Table 41. Global Transdermal Skin Patch Revenue by Application (2027-2032) & (W Units) Table 42. Global Transdermal Skin Patch Revenue Market Share by Application (2021-2026) Table 43. Global Transdermal Skin Patch Revenue Market Share by Application (2027-2032) Table 44. Global Transdermal Skin Patch Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Transdermal Skin Patch Sales by Region (2021-2026) & (W Units) Table 46. Global Transdermal Skin Patch Sales Market Share by Region (2021-2026) Table 47. Global Transdermal Skin Patch Sales Forecasted by Region (2027-2032) & (W Units) Table 48. Global Transdermal Skin Patch Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Transdermal Skin Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. North America Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 51. North America Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 52. Europe Transdermal Skin Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Europe Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 54. Europe Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 55. Asia Pacific Transdermal Skin Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Asia Pacific Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 57. Asia Pacific Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 58. South America, Middle East and Africa Transdermal Skin Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. South America, Middle East and Africa Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 60. South America, Middle East and Africa Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 61. Global Transdermal Skin Patch Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Transdermal Skin Patch Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Transdermal Skin Patch Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Transdermal Skin Patch Revenue Market Share by Region (2021-2026) Table 65. Global Transdermal Skin Patch Revenue Market Share by Region (2027-2032) Table 66. Actavis Company Information Table 67. Actavis Business Overview Table 68. Actavis Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Actavis Transdermal Skin Patch Product Portfolio Table 70. Actavis Recent Development Table 71. Changzhou Siyao Company Information Table 72. Changzhou Siyao Business Overview Table 73. Changzhou Siyao Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Changzhou Siyao Transdermal Skin Patch Product Portfolio Table 75. Changzhou Siyao Recent Development Table 76. Henan Lingrui Pharmaceutical Company Information Table 77. Henan Lingrui Pharmaceutical Business Overview Table 78. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio Table 80. Henan Lingrui Pharmaceutical Recent Development Table 81. Hisamitsu Pharmaceutical Company Information Table 82. Hisamitsu Pharmaceutical Business Overview Table 83. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio Table 85. Hisamitsu Pharmaceutical Recent Development Table 86. Luye Pharma Group Ltd. Company Information Table 87. Luye Pharma Group Ltd. Business Overview Table 88. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio Table 90. Luye Pharma Group Ltd. Recent Development Table 91. Mundipharma Company Information Table 92. Mundipharma Business Overview Table 93. Mundipharma Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Mundipharma Transdermal Skin Patch Product Portfolio Table 95. Mundipharma Recent Development Table 96. Purdue Pharma L.P. Company Information Table 97. Purdue Pharma L.P. Business Overview Table 98. Purdue Pharma L.P. Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio Table 100. Purdue Pharma L.P. Recent Development Table 101. Rfl Pharmaceutical Company Information Table 102. Rfl Pharmaceutical Business Overview Table 103. Rfl Pharmaceutical Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio Table 105. Rfl Pharmaceutical Recent Development Table 106. Teikoku Pharma Company Information Table 107. Teikoku Pharma Business Overview Table 108. Teikoku Pharma Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Teikoku Pharma Transdermal Skin Patch Product Portfolio Table 110. Teikoku Pharma Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Mylan Transdermal Skin Patch Product Portfolio Table 115. Mylan Recent Development Table 116. Novartis Company Information Table 117. Novartis Business Overview Table 118. Novartis Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Novartis Transdermal Skin Patch Product Portfolio Table 120. Novartis Recent Development Table 121. Johnson & Johnson Company Information Table 122. Johnson & Johnson Business Overview Table 123. Johnson & Johnson Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Johnson & Johnson Transdermal Skin Patch Product Portfolio Table 125. Johnson & Johnson Recent Development Table 126. Teva Pharmaceutical Industries Ltd. Company Information Table 127. Teva Pharmaceutical Industries Ltd. Business Overview Table 128. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio Table 130. Teva Pharmaceutical Industries Ltd. Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Transdermal Skin Patch Distributors List Table 134. Transdermal Skin Patch Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Transdermal Skin Patch Product Image Figure 2. Global Transdermal Skin Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Skin Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Skin Patch Sales (2021-2032) & (W Units) Figure 5. Global Transdermal Skin Patch Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Transdermal Skin Patch Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Buprenorphine Transdermal Skin Patch Image Figure 9. Fentanyl Transdermal Skin Patch Image Figure 10. Clonidine Transdermal Skin Patch Image Figure 11. Nicotine Transdermal Skin Patch Image Figure 12. Global Transdermal Skin Patch Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Transdermal Skin Patch Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Transdermal Skin Patch Sales Market Share by Type (2021-2032) Figure 15. Global Transdermal Skin Patch Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Transdermal Skin Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Transdermal Skin Patch Revenue Market Share by Type (2021-2032) Figure 18. Relieve Severe Pain Image Figure 19. Stop Smoking Cigarettes Image Figure 20. Treat an Overactive Bladder Image Figure 21. Others Image Figure 22. Global Transdermal Skin Patch Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Transdermal Skin Patch Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Transdermal Skin Patch Sales Market Share by Application (2021-2032) Figure 25. Global Transdermal Skin Patch Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Transdermal Skin Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Transdermal Skin Patch Revenue Market Share by Application (2021-2032) Figure 28. North America Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 29. North America Transdermal Skin Patch Sales Market Share by Country (2021-2032) Figure 30. U.S. Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Canada Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Mexico Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Transdermal Skin Patch Sales Market Share by Country (2021-2032) Figure 35. Germany Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 36. France Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 37. U.K. Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Italy Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Netherlands Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Transdermal Skin Patch Sales Market Share by Country (2021-2032) Figure 42. China Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Japan Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South Korea Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Southeast Asia Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 46. India Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Australia Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Transdermal Skin Patch Sales Market Share by Country (2021-2032) Figure 50. Brazil Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South Africa Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Saudi Arabia Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Turkey Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Argentina Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 55. UAE Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Egypt Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Chile Transdermal Skin Patch Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Global Transdermal Skin Patch Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Transdermal Skin Patch Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Figure 61. North America Transdermal Skin Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Figure 63. Europe Transdermal Skin Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Transdermal Skin Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Transdermal Skin Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Transdermal Skin Patch Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Transdermal Skin Patch Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Buprenorphine Transdermal Skin Patch
  • Fentanyl Transdermal Skin Patch
  • Clonidine Transdermal Skin Patch
  • Nicotine Transdermal Skin Patch
Applications
  • Relieve Severe Pain
  • Stop Smoking Cigarettes
  • Treat an Overactive Bladder
  • Others
Companies covered
  • Actavis
  • Changzhou Siyao
  • Henan Lingrui Pharmaceutical
  • Hisamitsu Pharmaceutical
  • Luye Pharma Group Ltd.
  • Mundipharma
  • Purdue Pharma L.P.
  • Rfl Pharmaceutical
  • Teikoku Pharma
  • Mylan
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transdermal Skin Patch Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transdermal Skin Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Transdermal Skin Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Transdermal Skin Patch Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Transdermal Skin Patch Market Dynamics
  1. 2.1 Transdermal Skin Patch Industry Trends
  2. 2.2 Transdermal Skin Patch Industry Drivers
  3. 2.3 Transdermal Skin Patch Industry Opportunities and Challenges
  4. 2.4 Transdermal Skin Patch Industry Restraints
3 Transdermal Skin Patch Market by Manufacturers
  1. 3.1 Global Transdermal Skin Patch Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Transdermal Skin Patch Sales by Manufacturers (2021-2026)
  3. 3.3 Global Transdermal Skin Patch Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Transdermal Skin Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Skin Patch Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Transdermal Skin Patch Manufacturers, Product Type & Application
  7. 3.7 Global Transdermal Skin Patch Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Skin Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Skin Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Skin Patch Tier 1, Tier 2, and Tier 3
4 Transdermal Skin Patch Market by Type
  1. 4.1 Transdermal Skin Patch Type Introduction
  2. 4.1.1 Buprenorphine Transdermal Skin Patch
  3. 4.1.2 Fentanyl Transdermal Skin Patch
  4. 4.1.3 Clonidine Transdermal Skin Patch
  5. 4.1.4 Nicotine Transdermal Skin Patch
  6. 4.2 Global Transdermal Skin Patch Sales by Type
  7. 4.2.1 Global Transdermal Skin Patch Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Transdermal Skin Patch Sales by Type (2021-2032)
  9. 4.2.3 Global Transdermal Skin Patch Sales Market Share by Type (2021-2032)
  10. 4.3 Global Transdermal Skin Patch Revenue by Type
  11. 4.3.1 Global Transdermal Skin Patch Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Transdermal Skin Patch Revenue by Type (2021-2032)
  13. 4.3.3 Global Transdermal Skin Patch Revenue Market Share by Type (2021-2032)
5 Transdermal Skin Patch Market by Application
  1. 5.1 Transdermal Skin Patch Application Introduction
  2. 5.1.1 Relieve Severe Pain
  3. 5.1.2 Stop Smoking Cigarettes
  4. 5.1.3 Treat an Overactive Bladder
  5. 5.1.4 Others
  6. 5.2 Global Transdermal Skin Patch Sales by Application
  7. 5.2.1 Global Transdermal Skin Patch Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Transdermal Skin Patch Sales by Application (2021-2032)
  9. 5.2.3 Global Transdermal Skin Patch Sales Market Share by Application (2021-2032)
  10. 5.3 Global Transdermal Skin Patch Revenue by Application
  11. 5.3.1 Global Transdermal Skin Patch Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Transdermal Skin Patch Revenue by Application (2021-2032)
  13. 5.3.3 Global Transdermal Skin Patch Revenue Market Share by Application (2021-2032)
6 Global Transdermal Skin Patch Sales by Region
  1. 6.1 Global Transdermal Skin Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Skin Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Skin Patch Sales by Region (2021-2026)
  4. 6.2.2 Global Transdermal Skin Patch Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transdermal Skin Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Transdermal Skin Patch Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Transdermal Skin Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Transdermal Skin Patch Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Transdermal Skin Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Transdermal Skin Patch Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Transdermal Skin Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Transdermal Skin Patch Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Transdermal Skin Patch Revenue by Region
  1. 7.1 Global Transdermal Skin Patch Revenue by Region
  2. 7.1.1 Global Transdermal Skin Patch Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Transdermal Skin Patch Revenue by Region (2021-2026)
  4. 7.1.3 Global Transdermal Skin Patch Revenue by Region (2027-2032)
  5. 7.1.4 Global Transdermal Skin Patch Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Transdermal Skin Patch Revenue (2021-2032)
  8. 7.2.2 North America Transdermal Skin Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Transdermal Skin Patch Revenue (2021-2032)
  11. 7.3.2 Europe Transdermal Skin Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Transdermal Skin Patch Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Transdermal Skin Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Transdermal Skin Patch Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Transdermal Skin Patch Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis
  2. 8.1.1 Actavis Company Information
  3. 8.1.2 Actavis Business Overview
  4. 8.1.3 Actavis Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Transdermal Skin Patch Product Portfolio
  6. 8.1.5 Actavis Recent Developments
  7. 8.2 Changzhou Siyao
  8. 8.2.1 Changzhou Siyao Company Information
  9. 8.2.2 Changzhou Siyao Business Overview
  10. 8.2.3 Changzhou Siyao Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
  12. 8.2.5 Changzhou Siyao Recent Developments
  13. 8.3 Henan Lingrui Pharmaceutical
  14. 8.3.1 Henan Lingrui Pharmaceutical Company Information
  15. 8.3.2 Henan Lingrui Pharmaceutical Business Overview
  16. 8.3.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
  18. 8.3.5 Henan Lingrui Pharmaceutical Recent Developments
  19. 8.4 Hisamitsu Pharmaceutical
  20. 8.4.1 Hisamitsu Pharmaceutical Company Information
  21. 8.4.2 Hisamitsu Pharmaceutical Business Overview
  22. 8.4.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
  24. 8.4.5 Hisamitsu Pharmaceutical Recent Developments
  25. 8.5 Luye Pharma Group Ltd.
  26. 8.5.1 Luye Pharma Group Ltd. Company Information
  27. 8.5.2 Luye Pharma Group Ltd. Business Overview
  28. 8.5.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
  30. 8.5.5 Luye Pharma Group Ltd. Recent Developments
  31. 8.6 Mundipharma
  32. 8.6.1 Mundipharma Company Information
  33. 8.6.2 Mundipharma Business Overview
  34. 8.6.3 Mundipharma Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mundipharma Transdermal Skin Patch Product Portfolio
  36. 8.6.5 Mundipharma Recent Developments
  37. 8.7 Purdue Pharma L.P.
  38. 8.7.1 Purdue Pharma L.P. Company Information
  39. 8.7.2 Purdue Pharma L.P. Business Overview
  40. 8.7.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
  42. 8.7.5 Purdue Pharma L.P. Recent Developments
  43. 8.8 Rfl Pharmaceutical
  44. 8.8.1 Rfl Pharmaceutical Company Information
  45. 8.8.2 Rfl Pharmaceutical Business Overview
  46. 8.8.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
  48. 8.8.5 Rfl Pharmaceutical Recent Developments
  49. 8.9 Teikoku Pharma
  50. 8.9.1 Teikoku Pharma Company Information
  51. 8.9.2 Teikoku Pharma Business Overview
  52. 8.9.3 Teikoku Pharma Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
  54. 8.9.5 Teikoku Pharma Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Transdermal Skin Patch Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis Transdermal Skin Patch Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Johnson & Johnson
  68. 8.12.1 Johnson & Johnson Company Information
  69. 8.12.2 Johnson & Johnson Business Overview
  70. 8.12.3 Johnson & Johnson Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
  72. 8.12.5 Johnson & Johnson Recent Developments
  73. 8.13 Teva Pharmaceutical Industries Ltd.
  74. 8.13.1 Teva Pharmaceutical Industries Ltd. Company Information
  75. 8.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
  76. 8.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
  78. 8.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Skin Patch Value Chain Analysis
  2. 9.1.1 Transdermal Skin Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Skin Patch Production Mode & Process
  6. 9.2 Transdermal Skin Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Skin Patch Distributors
  9. 9.2.3 Transdermal Skin Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst